Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 3 of 3 entries
Sorted by: Best Match Show Resources per page
ERRα regulates the growth of triple-negative breast cancer cells via S6K1-dependent mechanism.

Signal transduction and targeted therapy

Berman AY, Manna S, Schwartz NS, Katz YE, Sun Y, Behrmann CA, Yu JJ, Plas DR, Alayev A, Holz MK.
PMID: 28890840
Signal Transduct Target Ther. 2017;2. doi: 10.1038/sigtrans.2017.35. Epub 2017 Aug 25.

Estrogen-related receptor alpha (ERRα) is an orphan nuclear factor that is a master regulator of cellular energy metabolism. ERRα is overexpressed in a variety of tumors, including ovarian, prostate, colorectal, cervical and breast, and is associated with a more...

Cite
Berman AY, Manna S, Schwartz NS, et al. ERRα regulates the growth of triple-negative breast cancer cells via S6K1-dependent mechanism. Signal Transduct Target Ther. 2017;2doi: 10.1038/sigtrans.2017.35.
Berman, A. Y., Manna, S., Schwartz, N. S., Katz, Y. E., Sun, Y., Behrmann, C. A., Yu, J. J., Plas, D. R., Alayev, A., & Holz, M. K. (2017). ERRα regulates the growth of triple-negative breast cancer cells via S6K1-dependent mechanism. Signal transduction and targeted therapy, 2. https://doi.org/10.1038/sigtrans.2017.35
Berman, Adi Y, et al. "ERRα regulates the growth of triple-negative breast cancer cells via S6K1-dependent mechanism." Signal transduction and targeted therapy vol. 2 (2017). doi: https://doi.org/10.1038/sigtrans.2017.35
Berman AY, Manna S, Schwartz NS, Katz YE, Sun Y, Behrmann CA, Yu JJ, Plas DR, Alayev A, Holz MK. ERRα regulates the growth of triple-negative breast cancer cells via S6K1-dependent mechanism. Signal Transduct Target Ther. 2017;2. doi: 10.1038/sigtrans.2017.35. Epub 2017 Aug 25. PMID: 28890840; PMCID: PMC5589335.
Copy Download .nbib Format: NLM
The therapeutic potential of resveratrol: a review of clinical trials.

NPJ precision oncology

Berman AY, Motechin RA, Wiesenfeld MY, Holz MK.
PMID: 28989978
NPJ Precis Oncol. 2017;1. doi: 10.1038/s41698-017-0038-6. Epub 2017 Sep 25.

Resveratrol is a nutraceutical with several therapeutic effects. It has been shown to mimic effects of caloric restriction, exert anti-inflammatory and anti-oxidative effects, and affect the initiation and progression of many diseases through several mechanisms. While there is a...

Cite
Berman AY, Motechin RA, Wiesenfeld MY, et al. The therapeutic potential of resveratrol: a review of clinical trials. NPJ Precis Oncol. 2017;1doi: 10.1038/s41698-017-0038-6.
Berman, A. Y., Motechin, R. A., Wiesenfeld, M. Y., & Holz, M. K. (2017). The therapeutic potential of resveratrol: a review of clinical trials. NPJ precision oncology, 1. https://doi.org/10.1038/s41698-017-0038-6
Berman, Adi Y, et al. "The therapeutic potential of resveratrol: a review of clinical trials." NPJ precision oncology vol. 1 (2017). doi: https://doi.org/10.1038/s41698-017-0038-6
Berman AY, Motechin RA, Wiesenfeld MY, Holz MK. The therapeutic potential of resveratrol: a review of clinical trials. NPJ Precis Oncol. 2017;1. doi: 10.1038/s41698-017-0038-6. Epub 2017 Sep 25. PMID: 28989978; PMCID: PMC5630227.
Copy Download .nbib Format: NLM
Tamoxifen Action in ER-Negative Breast Cancer.

Signal transduction insights

Manna S, Holz MK.
PMID: 26989346
Sign Transduct Insights. 2016 Feb 10;5:1-7. doi: 10.4137/STI.S29901.

Breast cancer is a highly heterogeneous disease. Tamoxifen is a selective estrogen receptor (ER) modulator and is mainly indicated for the treatment of breast cancer in postmenopausal women and postsurgery neoadjuvant therapy in ER-positive breast cancers. Interestingly, 5-10% of...

Cite
Manna S, Holz MK. Tamoxifen Action in ER-Negative Breast Cancer. Sign Transduct Insights. 2016;5:1-7doi: 10.4137/STI.S29901.
Manna, S., & Holz, M. K. (2016). Tamoxifen Action in ER-Negative Breast Cancer. Signal transduction insights, 51-7. https://doi.org/10.4137/STI.S29901
Manna, Subrata, and Holz, Marina K. "Tamoxifen Action in ER-Negative Breast Cancer." Signal transduction insights vol. 5 (2016): 1-7. doi: https://doi.org/10.4137/STI.S29901
Manna S, Holz MK. Tamoxifen Action in ER-Negative Breast Cancer. Sign Transduct Insights. 2016 Feb 10;5:1-7. doi: 10.4137/STI.S29901. PMID: 26989346; PMCID: PMC4792287.
Copy Download .nbib Format: NLM
Showing 1 to 3 of 3 entries